COVID-19 wrapup
From The New England Council’s (newenglandcouncil.com) latest wrap up of COVID-19 news:
“Eli Lilly Find Drug to Improve Clinical Outcomes – Eli Lilly and Company has found that baricitinib, used alongside remdesivir, reduces recovery time and improves clinical outcomes for patients infected with COVID-19 more so than patients treated only with remdesivir. Eli Lilly originally developed baricitinib – marketed at Olumiant – as a treatment for rheumatoid arthritis, but has been studying the drug as a COVID-19 treatment as part of a trial sponsored by the National Institute of Allery and Infectious Diseaseas (NIAID). The most signifiant impact was observed in patients placed on supplemental oxygen. Read more here.
“Harvard Street Neighborhood Health Center Utilizes Mobile COVID-19 Testing Unit – Early in the pandemic, Harvard Street Neighborhood Health Center launched a mobile COVID-19 testing unit, which has since tested thousands of patients at Dudley Square, Prince Grand Hall Lodge, Children’s Services of Roxbury and other locations. Read more here.
“Blue Cross Blue Shield of Massachusetts Grants Additional $400,00 to COVID-19 Fund – Blue Cross Blue Shield has donated $400,000 to go towards supporting communities of color most affected by the pandemic, as well as Massachusetts regional funds community health centers, nonprofits, and teacher organizations. Read more here.’’
Largest self-reported ancestry groups in New England. Americans of Irish descent form a plurality in most of Massachusetts, while Americans of English descent form a plurality in much of central Vermont and New Hampshire as well as nearly all of Maine.